Emboline Raises Over $10 Million in Series C Funding: Funds Raised To Be Used to Obtain Initial Commercial Approval of the Emboliner & Launch of a US IDE Clinical Study

xEmboline recently completed the 3-center, 31-patient SafePass 2 study of the Emboliner™ in New Zealand in which the device met all primary endpoints for safety and technical performance when used during TAVR.

Ensysce Biosciences Secures $60 Million Capital Commitment From Global Emerging Markets

Ensyce Biosciences notes under the accord, GEM agrees to provide Ensysce with a share subscription facility of up to $60 million for a 36-month term following the public listing of the Company's common stock.

AIVITA Biomedical Successfully Closes $25 Million Financing Round: Funds Support Ongoing Development of Personalized COVID-19 Prevention Vaccine

The roceeds will support clinical development of AIVITA's personalized immunotherapy programs.

Coagulo Medical Technologies Raises $6.5 Million in Financing: To Accelerate Delivery of Disruptive Coagulation Diagnostics Platform

The company also announced that it has been awarded a Small Business Innovation Research (SBIR) grant by the National Science Foundation to accelerate delivery of breakthrough innovations amid the global COVID–19 public health crisis, which has called attention to the limitations of conventional coagulation tests.

Heru Completes FDA Registration Following a $2.7M Seed Round: Expands Leadership Team

The funding facilitates the completion of current clinical trials for FDA clearance of Heru’s wearable AI platform and subsequent commercialization efforts.

Peptilogics Closes $35.4 Million Series B Financing

The proceeds of the financing will be used to expand Peptilogics' computational platform and invest in technologies to improve its drug design engine, as well as accelerate the development of a pipeline of peptide therapeutics

Verily Announces $700 Million Investment Round from Current Investors: Funds to Support Rapid Commercial Expansion

Verily current investors, include Alphabet, Silver Lake, Temasek, Ontario Teachers’ Pension Plan and others.

Pacific6 Enterprises and JM Molina Investments Announce a Joint Investment in Detact Diagnostics

Pacific6 is an investment partnership founded, in part, by John Molina, the former CFO of Molina Healthcare. His brother, J. Mario Molina, M.D., former CEO of Molina Healthcare, is the principal behind JM Molina Investments.